General form of registration statement for all companies including face-amount certificate companies

Subsequent Events (Details Narrative) (10-K)

v3.10.0.1
Subsequent Events (Details Narrative) (10-K) - USD ($)
 1 Months Ended 6 Months Ended
Oct. 04, 2017
Mar. 31, 2018
Jan. 31, 2018
Jun. 30, 2018
Jun. 30, 2017
Mar. 19, 2018
Dec. 31, 2017
Dec. 31, 2016
Number of common stock shares outstanding       38,674,265     35,272,626 31,745,242
Gross proceeds from equity or other financing       $ 117,339      
Loss on cyber security fraud       $ 144,200        
Parent Company [Member]                
Number of common stock shares outstanding             246,907,902  
CoNCERT Pharmaceuticals, Inc [Member]                
Number of common stock shares outstanding           35,272,626    
Gross proceeds from equity or other financing $ 8,000,000              
Subsequent Event [Member]                
Percentage of sublicense revenue earned   15.00%            
Loss on cyber security fraud     $ 144,200          
Subsequent Event [Member] | Parent Company [Member]                
Percentage of sublicense revenue earned   0.00%            
Gross proceeds from equity or other financing   $ 8,000,000            
Sublicense revenue   8,000,000            
Subsequent Event [Member] | CoNCERT Pharmaceuticals, Inc [Member]                
Amount of common stock owned   $ 8,000,000            
Number of common stock shares outstanding   2,090,300            
Subsequent Event [Member] | Promet Therapeutics, LLC [Member]                
Common stock percentage   6.58%            
Common stock issued and outstanding percentage   5.93%